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Summary Misclassification of the oestrogen status of a human breast tumour cytosol, arising from different
sources and magnitudes of error in the dextran-coated charcoal (DCC) method, have been investigated using
both practical and computer simulated data analysed by Scatchard and Mass Action models. The minimum
detectable receptor site concentration, relative or absolute numerical bias and imprecision which are complex
and integral functions of misclassification, have been calculated from practical data and for a range of
experimental conditions likely to be encountered in practice. The Mass Action model was found to be
superior and the computer program, designed to investigate the effects of methodological errors on
quantitative aspects of the assay, may be a useful aid for analytical design and internal quality control of the
receptor assay.
There is now considerable evidence to indicate that
the management of patients with carcinoma of the
breast can be improved by the use of oestradiol-17#
receptor (ER) assays (McGuire et al., 1975). In
patients with advanced disease, there is a good
correlation between the receptor status of
metastatic tissue and response to endocrine therapy
(McGuire et al., 1978). Furthermore, not only has a
good relationship been observed between the
receptor status of the primary tumour and
subsequent response of the patient when the disease
recurs (Jensen et al., 1976; Nicholson et al., 1981)
but the receptor status, in association with various
clinical parameters, such as tumour grade and
nodal involvement, may be of particular value for
the selection of high risk patients for adjuvant
therapy following mastectomy (Haybittle et al.,
1982). A recent gathering of experts (Consensus
Meeting, 1980), has, however, confirmed the
effectiveness of the dextran-coated charcoal (DCC)
receptor assay for the determination of receptor
levels and it now forms the basis on which
prognostic investigations are currently being
established.
This report evaluates the effect of certain
practical inefficiencies in this methodology, such as
the presence of non-specific binding which can
affect quantitation (Wilson et al., 1971; Chamness
& McGuire, 1975). By using the appropriate model
for curve-fitting of binding data, the study provided
estimates of oestrogen receptor concentrations that
can be distinguished from zero, based on either the
probability of detection, using practical laboratory
data, or criteria derived from computer simulation
studies. The data generated are of interest in
relation to the establishment of the hormone
sensitivity of tumours with low cytosol receptor
levels and may be useful in assessing the possibly
improved procedures for receptor measurement
using monoclonal antibodies to receptor protein.
Materials and methods
Oestradiol-17/B receptor assay
Breast tumour tissue was stored in liquid N2 and
assayed within 2-3 weeks after surgery. Tissue
(%0.5g) was cut into small pieces, pulverised into a
fine powder in an all-glass homogeniser in 3 ml
buffer (1OmM TRIS; 1 mM EDTA; 10% v/v
glycerol; 5mM dithiothreitol; pH =7.4). The high
speed supernatant (100pl; 105,000 g for 60min) was
incubated for 16h at 4°C with lOOul of one of 10
concentrations of [3H] oestradiol (Sp.
act. - 100Cimmol-1), ranging from 0.2-
5.0 nmol 1 buffer. Aliquots of these solutions were
taken for counting and from a knowledge of the
counting efficiency and the specific activity a
"better" estimate of oestradiol mass added to the
incubation medium was calculated. Similar
incubations were established in the absence of
cytosol to assess the inefficiency of the procedure
for separating free from bound hormone, which
used DCC (200 gl; 0.5% gelatin, 0.05% dextran;
0.5% charcoal in TRIS buffer; 30min at 4°C).
Parallel incubations contained 100-fold excess of
diethylstilboestrol at each oestradiol concentration
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to assess non-specific binding. This assay has been
used for all the receptor analyses associated with
the Tenovus-Nottingham breast studies (Nicholson
et al., 1981).
Protein determination
The BIORAD assay kit (BIORAD, Dachauer
Strasse 364, Miinchen, FRG) based on the method
of Bradford (1976) was used for the determination
of protein in breast tumour cytosol with bovine
serum albumin as the protein standard. The cytosol
(100pl) was diluted in 0.15 M NaCl (900pl) and
100pl of the final solution was taken for assay in
duplicate. The standard curve was set up using
duplicate standards of 0, 10, 20, 40, 60 and
80,igml1. A linear regression analysis of optical
density versus concentration enabled confidence
limits of the standard curve to be established.
Statistical analysis
The practical data provided the total count rate (T)
in the incubation medium which is a measure
relating to oestradiol concentration, the inefficiency
(X) of charcoal adsorption of free steroid, and the
observed non-specific (NSB) and specific (S) count
rates bound to the receptor site. Equations were
derived to obtain estimates of the following true
parameters: non-specific (N) and specific (S') count
rates bound to receptor sites; the "available"
hormone concentration, which is related to the
count rate (T') that is free to react with specific
binding sites; and the ratio of specifically bound to
free oestradiol (R) in the incubation. These
equations are published elsewhere by Richards et
al. (1983).
The corrected binding data were then used to
elicit the binding site concentration (q), using least
squares regression analysis based on the linear
Scatchard and non-linear Mass Action models. The
relative biases associated with these models were
then assessed. The sensitivity of detecting receptor
levels as being distinct from zero was also evaluated
using these corrected binding data. The accuracy
of the Scatchard and non-linear Mass Action
models and the effect of practical inefficiencies on
the magnitude of receptor site concentration
estimates, were also assessed by computer
simulation. Chosen values of receptor site
concentration and equilibrium association constant
for the incubation, together with selected values for
the mean and standard deviation of X, N and S';
enabled 40 sets of "practical" data to be generated
at each receptor level using a Monte Carlo analysis
technique based on the general Law of Mass
Action. These simulated data were then re-analysed
by the Scatchard and non-linear Mass Action
models. It is important to emphasize that both
models are different mathematical forms of the
same mass action model. Consequently, this report
is concerned with the statistical implications
associated with the estimation of receptor site
concentration using both these forms of the Mass
Action model which are independent of the way the
data have been generated. A more detailed account
of the computer simulation and analysis is
published elesewhere by Richards et al. (1983).
Results and discussion
Comparison of methods for calculating receptor site
concentration
The two methods for calculating the receptor site
concentration in primary breast tumour cytosol
were compared (Figure 1) for 23 sets of binding
data, chosen at random, derived from the assay
technique described. To aid visual comparison,
values for the receptor site concentration were
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Figure 1 Comparison of Scatchard (A) and non-
linear least squares analysis of the Mass Action Model
(0) using corrected binding data. Data are ranked
according to non-linear estimates and a curve is drawn
to aid visual assessment.
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ranked in ascending order of magnitude based on
the non-linear least squares Mass Action model and
an arbitrary curve drawn through the points for
visual continuity. In nearly all cases (21/23), the
non-linear analysis gave lower values than the
Scatchard model. Clearly, a different figure based
on ascending order of Scatchard values could be
drawn but the conclusions of relative bias remain
unchanged. The accuracy and precision of both
models were investigated using Monte Carlo
analysis. The non-linear Mass Action model was
found to be superior (Table I).
As an example, the coefficient of variation of
an assay result (CVR/p) expressed in fmolmg-1
protein (Rf/p) was determined using the propagation
of errors method (Melissinos, 1966) such that
CVR/P= I00(,,/uR+(Rf/p 1p.)2/P)/[Rf/p]
where the standard deviation of receptor and pro-
tein measurements are denoted by oR and up respec-
tively and the corresponding mean values for the
receptorandproteinconcentrations aregivenbyRand
P. In this example, R=8.7, P=0.242, UR = 1.31, Up =
0.0121 which leads to an assay result of36 fmolmg-
I
Table I Minimum detectable receptor site concentration (MDRC) and associated bias and precision for Scatchard (S)
and Mass Action (MA) models (fmol 100ji1 1 cytosol).
Non-specific binding (N)
N=5% N=10%
Parameter %CV(s) %CV(s')
lO 20 30 10 20 30
MA S MA S MA S MA S MA S MA S
True MDRC 1 5 2 14 4 5 9 4 18a 8
Calculated MDRC, q 1.4 6.2 2.4 21.0 4.9 - 5.8 12.0 5.8 31.8 10.0 SD(q) 1.2 0.8 1.2 3.6 2.2 2.4 2.5 3.8 19.0 6.1
%CV 86 13 50 17 45 - 41 21 66 60 61
%BIAS 40 24 20 50 23 16 33 45 77a 25
K=0.5 x 1010LM -1; X 1%; CV(X) =30%; CV(Non-specific binding)=10%.
aThe closest solution but does not satisfy criterion for bias.
Limits ofdetection: Practical data
Using this Mass Action model, attention was
focused on the statistical uncertainties associated
with measuring low values of receptor site
concentrations so that the probability of detecting
receptor levels distinct from zero, could be
established and possible misclassification of
receptor status in tumours minimized. Analysis of
samples, (n =5), chosen at low receptor site
concentrations ranging from 8.7-14.6fmol 100pl -1
cytosol and protein content ranging from 0.24-
0.54mg 100 ul -1 cytosol, when expressed as
fmolmg-t of protein, ranged from 23.2 to 36.0.
The pooled variance of the receptor estimations was
2.37 (fmolmg-1 protein)2 and the estimated
standard deviation for protein concentrations
between 0.2 to 0.6mg I00pl-I cytosol was .-5% of
the mean value, this being obtained from the
pooled sample variance obtained from 12 samples
of cytosol.
protein with acoefficient ofvariation (CVR,P) of 16%.
Under routine conditions, 5% of the samples
have a protein concentration in the cytosol of
<0.l0mg 1OO ul-1, therefore the protein content
requires re-analysis at lower dilutions to increase
precision of measurement otherwise the final result
may be considerably biased and will substantially
affect the uncertainties associated with the value of
the receptor level when expressed in fmolmg-1
protein. In any case, the distribution of standards in
the assay militate against precise estimates of
protein concentrations below 0.10mg 100il-1 and
the standard practice is to re-assay the cytosol at a
lower dilution. The minimum detectable receptor
concentration, AR is defined as, AR=K' 4R + AR
If the constant K', selected on the basis of a
percentage point for a Normal distribution, is equal
to >/2 ("standard deviations") and the variance in
detecting "zero" receptor concentration (U2) is
equal to the variance at AR,496 D.W. WILSON et al.
(a'^), a questionable assumption, then AR=
2 2.37 3 fmol which can be detected with a
probability of 97.5%. A receptor value of 3fmol
would have its 95% confidence bounded by 0 and
6.0fmol, which is equivalent to 0 to 15fmolmg-1
protein, assuming the protein content is
0.4mg lOO1 l-1 cytosol with a negligible error of
estimation. Even at ap=0.04, this would be
equivalent to a receptor value within the 95%
confidence boundaries of 0 and 16fmolmg-1
protein. Clearly, since n=5 then the between sample
estimate of variance is subject to error; if samples
are available, n>8 is a preferrable basis for
calculating AR. Even so, (RA, has not been estimated
from a large sample size and so Student's t-
distribution rather than the normal distribution is
now used to calculate the detection limit. In the
case where the limit is based on 2 standard
deviations, the corresponding Student's t-value for
n= 5 is 2.78 for 4 degrees of freedom which
effectively increases estimates of the detection limit
still further.
Limits ofDetection: Simulated data
Simulation studies were undertaken to compare the
Scatchard and non-linear least squares models.
These used "corrected" data at low levels of
receptor concentration, for selected values of both
nonspecific binding and inefficiency of separating
free from bound oestradiol and their associated
uncertainties, together with those for specifically
bound ligand. Certain criteria were used in the
simulation studies, which are in-line with analytical
practice, to ascertain the "minimum" detectable
concentrations of receptor site distinguishable from
zero. These criteria were (a) that for the Scatchard
plot, 5% or less of the 40 data sets produced
negative receptor values and (b) for the non-linear
least squares method, 5% or less of the data sets
failed to provide a convergent solution in the
calculation of receptor content. To test the separate
effect of the inefficiency of separation, (X), and
non-specific binding, (N), on the minimum
detectable receptor site concentration, either X or N
were set equal to zero together with their respective
uncertainty and that of specific binding, as
described elsewhere (Richards et al., 1983).
However, an evaluation of the separate effects of
inefficiencies on the reliable estimation of
uncertainties for both models does not reflect the
practical situation where interactions of un-
certainties in from different sources of inefficiencies
in the analytical system are present. To overcome
this deficiency, not discussed by Richards et al., (1983), simulation studies of interacting sources of
uncertainty for receptor levels [where the
uncertainty in specific binding was 10%, 20% or
30%; non-specific binding was either 5% or 10%
with coefficients of variation of 10%; the
inefficiency of separating free from bound hormone
was 1% with a CV of 30% (conditions often
encountered in practice)] gave data summarized in
Table I. The parameters referred to in this table
require explanation. The true minimum detectable
receptor site concentration (MDRC) refers to the
minimum integer value of receptor site
concentration used to simulate binding data which
on subsequent analysis provided the minimum
calculated receptor site concentration which
satisfied criteria for the limit of detection. As can
be seen this limit is different for each method. The
difference between the true and calculated values of
MDRC, expressed as a percentage of the true
value, provide an estimate of bias in numerical
accuracy. The data in Table I indicate the
advantage of the Mass Action (MA) model in
detecting lower concentrations of receptor site
concentration. Estimates of imprecision are best
interpreted from the standard deviation (s.d.) since, by definition, the coefficient of variation (CV) approaches infinity as the value of q converges towards zero. For the purposes of further
comparison, the MA model has been evaluated
under the conditions of MDRC that can be
achieved using the Scatchard (S) model. Thus
comparable MA values for the true MDRC
(fmol 100pl-' cytosol) calculated MDRC (q), s.d.(q) and % bias under the same conditions as the
Scatchard model (represented in Table I by columns 3, 5, 9 and 11) are 5.0, 5.2, 1.2, 23%, 4%; 14.0, 14.4,4.5,31.3%, 2.9%; 9.0, 9.0,2.4, 27%, 0%; and 18.0, 19.8, 6.4, 32.3%, 10%, respectively. Although the imprecision of the Scatchard appears marginally better under conditions of low
uncertainties in the various parameters, under
conditions of high uncertainties the situation is
reversed and under all conditions so far tested, the
numerical accuracy of the MA model is superior. It
was observed that when the level of uncertainty in
specific binding was raised from 10% to 20% or
30%, greater difficulty was met when attempting to
obtain satisfactory solutions for both the Scatchard
plot and the non-linear squares analysis. Although it is impracticable to demonstrate all the
interactions of different sources and magnitudes of
methodological errors on imprecision, bias and
detection limits for the receptor assay, nevertheless
data may be generated by computer simulation
which clearly show the limitations of the Scatchard
and Mass Action models. Figure 2 illustrates the
superiority of the Mass Action model with respect to bias and detection limits for a non-specific binding level of 5% (CV=30%) for coefficients of
variation in specific binding of 5%, 10% or 20%.ANALYSIS OF THE OESTROGEN RECEPTOR ASSAY 497
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Figure 2 Comparison of calculated values of the mean receptor site concentration obtained from 40 sets of
simulated binding data at each true q level using the Scatchard (0), S, and non-linear Mass Action (El), MA,
models. Data are for X = 1%, CV(X) =30%; N =5%, CV(N) =30%; and the CV of specific binding is (a) 5%,
(b) 10% and (c) 20%. The figures in parentheses refer to the number of positive q values obtained from 40
simulations when they are less than 38. The straight lines represent the condition of zero bias and MDRC is
the minimum detectable receptor site concentration.
The value of the inefficiency of separating free from
bound hormone is 1% (CV=30%). The simulation
data in Table I and those in Figure 2 are
reproducible although some variation in the
detection limits is to be expected since different
sequences of random numbers are generated for
each run. To avoid ambiguity it is emphasized that
the coefficients of variation of X and N are
expressed as a percentage of the percentage
parameter mean. The computer program devised by
Richards et al. (1983) may also be used to optimize
the analytical procedure in terms of the distribution
of the various concentrations of labelled oestradiol
used in the assay and their order of replication.
This could be an important feature of the program
for use in a routine assay laboratory.
To illustrate the importance of sources of
uncertainty on the "analytical cut-off point", e.g.
5 fmol 100M1 1, representative sets of 40 receptor
site values at two levels of non-specific binding viz.
5% and 10%, with coefficients of variation of 10%
or 20% are shown in Figure 3. The increased bias
and imprecision of the Scatchard model are evident
and would be even more exaggerated when receptor
levels were expressed in fmolmg-1 protein,
assuming an average protein content of 0.4 mg
100pl-1 cytosol. At N=10% (CV=20%) only
25% of the generated receptor values are positive
using the Scatchard model compared with 95%
calculable values for the Mass Action model.
It must be emphasized that this report is intended
to illustrate, by practical experiment and computer
simulation, those factors which affect the minimum
detectable receptor concentration, estimates of the
precision of receptor measurements and their
numerical bias. Clearly, the model used in the
analysis is only meant to be an approximation since
levels of non-specific binding, expressed as a
percentage of each oestradiol concentration often
depart from linearity; such deviations cannot
readily be accommodated in a model that can have
general applicability in the field. Factors associated
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Figure 3 Comparison of receptor site concentrations obtained from 40 sets of simulated binding data using
Scatchard (----) and Mass Action ( ) models. The true equilibrium association constant and receptor site
concentration are 0.5 x 1010LM-1 and 5 fmol 100p1-I cytosol respectively. The coefficient of variation (CV)
in specific binding is 10%, the inefficiency of separation is 1% (CV=30%) and the non-specific binding is (a)
5% (CV=10%), (b) 5% (CV=20%), (c) 10% (CV=10%) and (d) 10% (CV=20%). The mean value (and
s.d.) are given for each data set in fmoll100 -1 cytosol. The breaks in the Mass Action profile in (d)
represent incalculable results; in the case of the Scratchard the co-ordinates are presented as solid circles.
with uncertainties arising from dissociation of the
bound complex, as discussed in a report by Wilson
et al. (1971), have not been incorporated in this
model. Although this is a relatively minor problem
for the oestradiol receptor assay it may be
important in other binding systems. The
mathematical model in terms of the response
variable, R, is not claimed to be the "best", neither
may a parametric model be the most robust
method of analysis. What is clear is that the
Scatchard model is not appropriate at low levels of
receptor concentration, particularly in the presence
of analytical "noise". Finally this report concerns,
inter alia, analytical cut-off levels for receptor
positivity in breast tumour cytosols. The degree of
cellularity (McGuire et al., 1977), and the existence
of clones of ER-positive and ER-negative cells
within the tumour, together with the presence of
"non-functional" or type II receptors in the cytosol,
may also influence the quantitative determination
of the receptor status of "tumour" tissue.
In conclusion, a computer simulation technique
has been described which allows a proper
assessment of the uncertainties associated with the
DCC method of assaying cytosolic oestradiol-17,B
receptor proteins in human breast cancer tissue. It
provides guide-lines for acceptable levels of
inefficiencies in the analytical system, together with
their uncertainties, as well as giving a more realistic
assessment of the minimum detectable receptor
concentration.
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